At the mechanistic level, this study suggests that SRC family kinases may regulate the immune microenvironment through non-ATP-competitive binding, while the ADRB2-GSK3B axis may participate in the interplay between metabolism and inflammation, providing potential targets for modulating the immunometabolic network in liver disease. This evidence concerns the gene ADRB2 and liver disorder.